Skip to main content

Advertisement

SpringerLink
Log in

Contribution of CSF cytology in the diagnostic work-up of breast cancer patients with neurological symptoms: a retrospective analysis over two decades

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

The aim of this study was to evaluate the contribution of cytological analysis of cerebrospinal fluid (CSF) in the diagnostic work-up of breast cancer patients who present with neurological symptoms suspected for central nervous system (CNS) metastases. In the period 1989–2009, a total of 81 patients with breast cancer underwent CSF cytological examination. Relevant tumour characteristics, clinical presentation and radiological findings were scored. The CSF cytological diagnosis was classified according to the 1996 NCI-sponsored conference approach as malignant, suspicious for malignancy, atypical, benign or inadequate. During the course of 20 years, 145 CSF cytological examinations were performed. Relatively common neurological symptoms resulting in cytological CSF examination were headache (n = 25), nausea and vomiting (n = 19), sensory disturbances (n = 16), and cranial nerve dysfunction (n = 16). Of these, headache and nausea/vomiting were most often associated with malignant cells in the CSF (CSF+) (in 48 and 53% of the cases, respectively). The 4 patients with both headache and confusion/altered mental status all had CSF+. In 10 patients, CSF+ was found despite the absence of radiological evidence for metastasis in/around the CNS. In our series, repeated CSF analysis appeared to have limited additional value, and CSF+ was strongly correlated with shorter survival. A substantial number of patients with neurological symptoms but without radiological abnormalities can have CSF+. In our series, the additional value of repeated cytological examination of CSF was limited. Our study underscores the value of CSF cytology as a tool for the unequivocal diagnosis of metastatic spread of breast cancer to the CNS, and confirms that CSF+ is a strong predictor of poor survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Chamberlain MC (2005) Neoplastic meningitis. J Clin Oncol 23:3605–3613

    Article  PubMed  Google Scholar 

  2. Chamberlain MC (2009) Leptomeningeal metastasis. Curr Opin Neurol 22:665–674

    Article  PubMed  CAS  Google Scholar 

  3. GM Chamberlain MC (2005) Cerebrospinal fluid-disseminated meningioma. Cancer 103:1427–1430

    Article  Google Scholar 

  4. Chamberlain MC, Kormanik PR (1997) Carcinomatous meningitis secondary to breast cancer: predictors of response to combined modality therapy. J Neurooncol 35:55–64

    Article  PubMed  CAS  Google Scholar 

  5. DeAngelis LM, Boutros D (2005) Leptomeningeal metastasis. Cancer Invest 23:145–154

    Article  PubMed  Google Scholar 

  6. Drappatz J, Batchelor TT (2007) Leptomeningeal neoplasms. Curr Treat Options Neurol 9:283–293

    Article  PubMed  Google Scholar 

  7. Grossman SA, Krabak MJ (1999) Leptomeningeal carcinomatosis. Cancer Treat Rev 25:103–119

    Article  PubMed  CAS  Google Scholar 

  8. Soffietti R, Akerley W, Jensen RL, Bischoff J, Regierer AC (2009) The role of intra-cerebrospinal fluid treatment and prophylaxis in patients with solid tumors. Semin Oncol 36(Suppl 2):S55–S68

    Article  PubMed  CAS  Google Scholar 

  9. Bendell JC, Domchek SM, Burstein HJ, Harris L, Younger J, Kuter I, Bunnell C, Rue M, Gelman R, Winer E (2003) Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Cancer 97:2972–2977

    Article  PubMed  Google Scholar 

  10. Platini C, Long J, Walter S (2006) Meningeal carcinomatosis from breast cancer treated with intrathecal trastuzumab. Lancet Oncol 7:778–780

    Article  PubMed  Google Scholar 

  11. Graesslin O, Abdulkarim BS, Coutant C, Huguet F, Gabos Z, Hsu L, Marpeau O, Uzan S, Pusztai L, Strom EA, Hortobagyi GN, Rouzier R, Ibrahim NK (2010) Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer. J Clin Oncol 28:2032–2037

    Article  PubMed  Google Scholar 

  12. Slimane K, Andre F, Delaloge S, Dunant A, Perez A, Grenier J, Massard C, Spielmann M (2004) Risk factors for brain relapse in patients with metastatic breast cancer. Ann Oncol 15:1640–1644

    Article  PubMed  CAS  Google Scholar 

  13. Tham YL, Sexton K, Kramer R, Hilsenbeck S, Elledge R (2006) Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer 107:696–704

    Article  PubMed  Google Scholar 

  14. Niwińska A, Murawska M, Pogoda K (2010) Breast cancer brain metastases differences in survival: depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT). Cancer 116:4238–4247

    Article  PubMed  Google Scholar 

  15. Balm M, Hammack J (1997) Leptomeningeal carcinomatosis. Presenting features and prognostic factors. Arch Neurol 54:16–17

    Article  Google Scholar 

  16. Heimann A, Merino MJ (1986) Carcinomatous meningitis as the initial manifestation of breast cancer. Acta Cytol 30:25–28

    PubMed  CAS  Google Scholar 

  17. Wesseling P, von Deimling A, Aldape KD (2007) WHO classification of tumours of the central nervous system, chapter 15, 4th edn. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) Metastatic tumours of the CNS. IARC, Lyon, pp 248–251

  18. Lee Y (1983) Breast carcinoma: pattern of metastasis at autopsy. J Surg Oncol 23:175–180

    Article  PubMed  CAS  Google Scholar 

  19. Tsukada Y, Fouad A, Pickren JW, Lane WW (1983) Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer 15:2349–2354

    Article  Google Scholar 

  20. Yap HY, Yap BS, Tashima CK, DiStefano A, Blumenschein GR (1978) Meningeal carcinomatosis in breast cancer. Cancer 42:283–286

    Article  PubMed  CAS  Google Scholar 

  21. Casparie M, Tiebosch AT, Burger G, Blauwgeers H, van de Pol A, van Krieken JH, Meijer GA (2007) Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 29:19–24

    PubMed  CAS  Google Scholar 

  22. The uniform approach to breast fine-needle aspiration biopsy (1997) NIH consensus development conference. Am J Surg 174:371–385

    Article  Google Scholar 

  23. Dufour H (1997) Classics in cytology. VIII: diffuse meningeal sarcomatosis with invasion of the spinal cord, the spinal roots. Positive cytological results, especially of the cerebrospinal fluid, 1904. Diagn Cytopathol 17:67–69

    Article  PubMed  CAS  Google Scholar 

  24. Glass JP, Melamed M, Chernik NL, Posner JB (1979) Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology 29:1369–1375

    PubMed  CAS  Google Scholar 

  25. Gleissner B, Chamberlain MC (2006) Neoplastic meningitis. Lancet Neurol 5:443–452

    Article  PubMed  Google Scholar 

  26. van Oostenbrugge RJ, Twijnstra A (1999) Presenting features and value of diagnostic procedures in leptomeningeal metastases. Neurology 53:382–385

    PubMed  Google Scholar 

  27. Boogerd W, Hart AA, van der Sande JJ, Engelsman E (1991) Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment. Cancer 67:1685–1695

    Article  PubMed  CAS  Google Scholar 

  28. Boogerd W, van den Bent MJ, Koehler PJ, Heimans JJ, van der Sande JJ, Aaronson NK, Hart AA, Benraadt J, ChJ Vecht (2004) The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study. Eur J Cancer 40:2726–2733

    Article  PubMed  CAS  Google Scholar 

  29. Schellinger PD, Meinck HM, Thron A (1999) Diagnostic accuracy of MRI compared to CCT in patients with brain metastases. J Neurooncol 44:275–281

    Article  PubMed  CAS  Google Scholar 

  30. Seute T, Leffers P, ten Velde GP, Twijnstra A (2008) Detection of brain metastases from small cell lung cancer: consequences of changing imaging techniques (CT versus MRI). Cancer 112:1827–1834

    Article  PubMed  Google Scholar 

  31. Ba-Ssalamah A, Nöbauer-Huhmann IM, Pinker K, Schibany N, Prokesch R, Mehrain S, Mlynárik V, Fog A, Heimberger K, Trattnig S (2003) Effect of contrast dose and field strength in the magnetic resonance detection of brain metastases. Invest Radiol 38:415–422

    PubMed  Google Scholar 

  32. Gupta RK, Naran S, Lallu S, Fauck R (2004) Cytodiagnosis of neoplasms of the central nervous system in cerebrospinal fluid samples with an application of selective immunostains in differentiation. Cytopathology 15:38–43

    Article  PubMed  CAS  Google Scholar 

  33. Jorda M, Ganjei-Azar P, Nadji M (1997) Cytologic characteristics of meningeal carcinomatosis: increased diagnostic accuracy using carcinoembryonic antigen and epithelial membrane antigen immunocytochemistry. Arch Neurol 55:181–184

    Article  Google Scholar 

  34. Kranz BR (2000) Detection of rare malignant cells and their apoptotic fragments in cerebrospinal fluid. Lancet 356:1242–1244

    Article  PubMed  CAS  Google Scholar 

  35. Twijnstra A, Ongerboer de Visser BW, van Zanten AP, Hart AA, Nooyen WJ (1989) Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors. J Neurooncol 7:57–63

    Article  PubMed  CAS  Google Scholar 

  36. Twijnstra A, van Zanten AP, Nooyen WJ, Ongerboer de Visser BW (1986) Sensitivity and specificity of single and combined tumour markers in the diagnosis of leptomeningeal metastasis from breast cancer. J Neurol Neurosurg Psychiatry 49:1246–1250

    Article  PubMed  CAS  Google Scholar 

  37. van Oostenbrugge RJ, Hopman AH, Arends JW, Ramaekers FC, Twijnstra A (1998) The value of interphase cytogenetics in cytology for the diagnosis of leptomeningeal metastases. Neurology 51:906–908

    PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Mrs. Chantal Huyben-van Leent for the excellent technical support and Mrs. I. de Kievit-van der Heijden, MD, PhD, for editing the text.

Conflict of interest

None.

Funding

None.

Author information

Authors and Affiliations

  1. Department of Pathology, Canisius-Wilhelmina Hospital, Weg door Jonkerbos 100, 6532 SZ, Nijmegen, The Netherlands

    C. A. P. Wauters & P. Wesseling

  2. Department of Neurology, Canisius-Wilhelmina Hospital, Weg door Jonkerbos 100, 6532 SZ, Nijmegen, The Netherlands

    J. Poelen

  3. Department of Education and Science, Canisius-Wilhelmina Hospital, Weg door Jonkerbos 100, 6532 SZ, Nijmegen, The Netherlands

    I. Mulder

  4. Department of Radiology, Canisius-Wilhelmina Hospital, Weg door Jonkerbos 100, 6532 SZ, Nijmegen, The Netherlands

    D. Venderink

  5. Department of Surgery, Canisius-Wilhelmina Hospital, Weg door Jonkerbos 100, 6532 SZ, Nijmegen, The Netherlands

    L. J. A. Strobbe

  6. Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

    P. Wesseling

Authors
  1. C. A. P. Wauters
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Poelen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Mulder
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Venderink
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. J. A. Strobbe
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. Wesseling
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. A. P. Wauters.

Additional information

This retrospective study was conducted following the rules of the ethical committee of our centre.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wauters, C.A.P., Poelen, J., Mulder, I. et al. Contribution of CSF cytology in the diagnostic work-up of breast cancer patients with neurological symptoms: a retrospective analysis over two decades. J Neurooncol 107, 581–589 (2012). https://doi.org/10.1007/s11060-011-0782-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-011-0782-3

Keywords

Search

Navigation